http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007053893-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9019a862fecbe535b865afa9976f36f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
filingDate 2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f164f206d24da4ab24ef76818e9f587
publicationDate 2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2007053893-A1
titleOfInvention Method of reducing immunological tolerance to malignancy
abstract Disclosed are therapeutic formulations comprising myristoylCoA and N-myristoyl transferase and methods of using such formulations to stimulate the immune system of a mammal afflicted with carcinoma and having a detectable blood level of unacylated A-protein to produce an immune response thereto. Also disclosed are methods of treating an A-protein displaying carcinoma in a mammal.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009088460-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8313917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009088460-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010284923-A1
priorityDate 1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5100661-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5079230-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443944
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129223725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128598070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136083391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57179954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127351521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129147512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414537

Total number of triples: 48.